国产中文无码av每日更新在线观看, 亚洲天堂中文字幕一区二区三区免费, 国产口爆吞精在线观视频-黄色国产, 92福利-国内精品久久久久久99,亚洲成AV人A片不卡无码,浪潮AV无码专区,老熟女败火白浆,中文字幕日产av,色情日本免费看大片

更新于 11月5日

IVBU-In Vitro Senior Scientist (Immunologist)

2.5-3.5萬(wàn)
  • 上海浦東新區(qū)
  • 經(jīng)驗(yàn)不限
  • 博士
  • 全職
  • 招1人

雇員點(diǎn)評(píng)標(biāo)簽

  • 工作環(huán)境好
  • 同事很nice
  • 團(tuán)隊(duì)執(zhí)行強(qiáng)
  • 氛圍活躍
  • 人際關(guān)系好
  • 免費(fèi)班車
  • 交通便利
  • 非常鍛煉人

職位描述

免疫
崗位職責(zé):
1. Project managing, design the study and provide guidance to the team to efficiently complete the projects
2. Be responsible for communicating with clients, fully understanding their needs and research purposes, and daily data updates, QA and troubleshooting during the project execution process.
3. Lead, mentor, and develop a high-performing team of scientists, be responsible for team expansion, training, and its daily operation. To enforce and meet EH&S and other operational requirement.
4. To optimize the current assay platform and develop new capabilities to meet market demands.
5. To work as a team with colleagues across various functions (at department, division, and company levels) in client service as well as capability buildup.
6. Provide scientific support to BDs and clients and deal with inquiries on WuXi Biology in vitro capabilities and data packs, working closely with the global team.
任職要求:
1. PhD in biology, immunology, oncology or related fields, or a MS with more than 5 years of relevant working experience.
2. Strong independent thinking ability, capable of independently analyzing and solving problems.
3. Expertise in research methods and contents related to the field of Immunology and Oncology, and autoimmune diseases.
4. Strong sense of responsibility, with a strong team spirit and cooperative awareness, able to fully communicate and coordinate the execution of projects within the team.
5. Strong English communication skills, with excellent listening, speaking, reading and writing abilities.

工作地點(diǎn)

浦東新區(qū)中國(guó)上海外高橋自貿(mào)區(qū)富特中路288號(hào)

職位發(fā)布者

劉先生/資深人力資源

昨日活躍
立即溝通
公司Logo藥明康德新藥開發(fā)有限公司
藥明康德(股票代碼:603259.SH/2359.HK)為全球醫(yī)藥及生命科學(xué)行業(yè)提供一體化、端到端的新藥研發(fā)和生產(chǎn)服務(wù),在亞洲、歐洲、北美等地均設(shè)有運(yùn)營(yíng)基地。藥明康德通過獨(dú)特的“CRDMO”業(yè)務(wù)模式,不斷降低研發(fā)門檻,助力客戶提升研發(fā)效率,為患者帶來(lái)更多突破性的治療方案,服務(wù)范圍涵蓋化學(xué)藥研發(fā)和生產(chǎn)、生物學(xué)研究、臨床前測(cè)試和臨床試驗(yàn)研究等領(lǐng)域。2024年,藥明康德連續(xù)第四年被MSCI評(píng)為ESG(環(huán)境、社會(huì)及管治)AA級(jí)。目前,公司的賦能平臺(tái)正承載著來(lái)自全球30多個(gè)國(guó)家約6,000家合作伙伴的研發(fā)創(chuàng)新項(xiàng)目,致力于將更多新藥、好藥帶給全球病患,早日實(shí)現(xiàn)“讓天下沒有難做的藥,難治的病”的愿景。
公司主頁(yè)